Advaxis entering into a master clinical trial agreement GRU Cancer Center - 0 views
-
Alex Parker on 07 Feb 14Advaxis, a biotechnology company developing the next generation of cancer immunotherapies, has expanded its relationship by entering into a master clinical trial agreement with GRU Cancer Center at Georgia Regents University to conduct four Phase I/II clinical trials.